• Explore /
  • Poster
  • / Early results from CASCARA: A phase 2 study of cabazitaxel/carboplatin plus abiraterone in high-volume metastatic castrate-sensitive prostate cancer (mCSPC).

Early results from CASCARA: A phase 2 study of cabazitaxel/carboplatin plus abiraterone in high-volume metastatic castrate-sensitive prostate cancer (mCSPC).

Abstract Poster

Authors

Charles Ryan

Charles J. Ryan

Prostate Cancer Foundation, Santa Monica, CA

Charles J. Ryan , Qing Cao , Andre Luiz De Souza , David James VanderWeele , Alan Haruo Bryce , William Kevin Kelly , Gautam Gopalji Jha , Pedro C. Barata , A. Oliver Sartor , Walter Michael Stadler , Mallika Sachdev Dhawan , Alicia K. Morgans , Emmanuel S. Antonarakis

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT03934840

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 5071)

DOI

10.1200/JCO.2023.41.16_suppl.5071

Abstract #

5071

Poster Bd #

165

Abstract Disclosures

Similar Posters

First Author: Xiao X. Wei

First Author: Di Maria Jiang

First Author: Sachdev P. Thomas

First Author: Boris Alexeev